Inventor
WU GUOXIAN
US45 patents
⚠️ This page may combine multiple inventors who share the name “WU GUOXIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PLEXXIKON INC
25 patentsUS7893075B2Feb 22, 2011
Compounds modulating c-fms and/or c-kit activity and uses therefor
PLEXXIKON INC96 citations99
US9469640B2Oct 18, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC44 citations98
US8722702B2May 13, 2014
Compounds modulating c-fms and/or c-kit activity and uses therefor
PLEXXIKON INC60 citations98
US7846941B2Dec 7, 2010
Compounds modulating c-kit and c-fms activity and uses therefor
PLEXXIKON INC92 citations98
US9814714B2Nov 14, 2017
Kinase modulation, and indications therefor
PLEXXIKON INC22 citations94
US9718847B2Aug 1, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC33 citations94
US9676748B2Jun 13, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC23 citations94
US9550768B2Jan 24, 2017
Kinase modulation and indications therefor
PLEXXIKON INC41 citations94
US9440969B2Sep 13, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC40 citations94
US7872018B2Jan 18, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC48 citations94
US9844539B2Dec 19, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US9938273B2Apr 10, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC17 citations85
US10426760B2Oct 1, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
US10301280B2May 28, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
US10227357B2Mar 12, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC7 citations84
US10428067B2Oct 1, 2019
Compounds and methods for kinase modulation
PLEXXIKON INC8 citations83
US10160747B2Dec 25, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC8 citations83
US10160755B2Dec 25, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC15 citations81
US11337976B2May 24, 2022
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC1 citations73
US10519177B2Dec 31, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC4 citations73
US10703757B2Jul 7, 2020
Compounds and methods for CDK8 modulation and indications therefor
PLEXXIKON INC4 citations71
US10508085B2Dec 17, 2019
Compounds and methods for IDO and TDO modulation, and indications therefor
PLEXXIKON INC6 citations71
US12076322B2Sep 3, 2024
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC0 citations63
US11149011B2Oct 19, 2021
Compounds and methods for IDO and TDO modulation, and indications therefor
PLEXXIKON INC2 citations60
US12509444B2Dec 30, 2025
Compounds and methods for CD73 modulation and indications therefor
PLEXXIKON INC0 citations48
MEDAREX INC
8 patentsUS7507420B2Mar 24, 2009
Peptidyl prodrugs and linkers and stabilizers useful therefor
MEDAREX INC148 citations98
US7498302B2Mar 3, 2009
Disulfide prodrugs and linkers and stabilizers useful therefor
MEDAREX INC123 citations98
US7129261B2Oct 31, 2006
Cytotoxic agents
MEDAREX INC282 citations98
US7087600B2Aug 8, 2006
Peptidyl prodrugs and linkers and stabilizers useful therefor
MEDAREX INC259 citations98
US6989452B2Jan 24, 2006
Disulfide prodrugs and linkers and stabilizers useful therefor
MEDAREX INC284 citations98
US8034959B2Oct 11, 2011
Methods of treating cancer with an antibody-drug conjugate
MEDAREX INC37 citations95
US7977465B2Jul 12, 2011
Peptidyl prodrugs and linkers and stabilizers useful therefor
MEDAREX INC14 citations92
USRE41252EApr 20, 2010
Peptidyl prodrugs and linkers and stabilizers useful therefor
MEDAREX INC3 citations71
RENOVIS INC
4 patentsUS7338950B2Mar 4, 2008
Amide compounds as ion channel ligands and uses thereof
RENOVIS INC18 citations83
US7312330B2Dec 25, 2007
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
RENOVIS INC8 citations72
US7576099B2Aug 18, 2009
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
RENOVIS INC5 citations60
US7414131B2Aug 19, 2008
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
RENOVIS INC0 citations40
IBRAHIM PRABHA N
3 patentsUS8404700B2Mar 26, 2013
Compounds modulating c-fms and/or c-kit activity and uses therefor
IBRAHIM PRABHA N63 citations98
US8198273B2Jun 12, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N65 citations98
US8415469B2Apr 9, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N84 citations97